Last updated on December 2019

Study of Nivolumab Versus Placebo in Participants With High-Risk Breast Cancer

Brief description of study

A randomized multi-arm study evaluating the safety and efficacy of nivolumab versus placebo in combination with paclitaxel in participants with ER+/HER2- breast cancer

Clinical Study Identifier: NCT04109066

Find a site near you

Start Over

Local Institution

Heidelberg, Australia
  Connect »

Local Institution

Melbourne, Australia
  Connect »